Food and Drug Administration
Anti-Infective Drugs Advisory Committee
February 20, 2002
Approaches to the development of antimicrobial agents for the treatment of resistant pathogens
Issues for Discussion - Questions (New 03/13/02) ppt htm
Slides
Antibiotic resistance: An Update, Janice Soreth, MD, Division of Anti-Infective Drug Products ppt htm
Developing Drugs for Resistant Pathogens: Problems and Possibilities, David Ross, MD, PhD ppt htm
Development of Antibacterial Drugs for Infections with Resistant Pathogens, David Shlaes, MD, Antimicrobial Working Group of the Pharmaceutical Research and Manufacturers of America (PhRMA) ppt htm
Resistance in NYC Seven Hospital Consortium, Louis Rice, MD on behalf of the Infectious Diseases Society of America (IDSA) ppt htm
Development of Drugs for Resistant Pathogens, Francis P Tally, MD, Cubist Pharmaceuticals, Inc. ppt htm
Open Public Hearing
Antibiotic Development Strategies to Understand and Label Microbial Endpoints such as Slow Killing, Resistance and Failure, AUIC Dosing and Success via Synergy, Jerome J Schentag, PharmD, University at Buffalo ppt htm
Prevention of Emergence of Resistance: A Pharmacodynamic Solution, G L Drusano, MD, Albany Medical College & New York State Department of Health ppt htm